Letter to the Editor: Effect of Intravitreal Bevacizumab Injection on Retinopathy of Prematurity.

Kim, Y C

doi:2015.56.10.1650

J Korean Ophthalmol Soc > Volume 56(10); 2015 > Article

Letter

Journal of the Korean Ophthalmological Society 2015;56(10):1650-1650.
DOI: https://doi.org/10.3341/jkos.2015.56.10.1650 Published online October 15, 2015.

Letter to the Editor: Effect of Intravitreal Bevacizumab Injection on Retinopathy of Prematurity.

Y C Kim

계명대학교 의과대학 동산의료원 안과학교실

미숙아 망막병증에서의 유리체강내 베바시주맙 주입술의 효과

김유철

계명대학교 의과대학 동산의료원 안과학교실

Received: 24 April 2015 • Revised: 16 July 2015 • Accepted: 4 September 2015

Abstract

No abstract available.

TOOLS

METRICS

0 Crossref
0 Scopus
868 View
0 Download

Related articles

Predictive Factors for Retreatment after Intravitreal Ranibizumab Injection to Treat Type 1 Retinopathy of Prematurity2023 September;64(9)

Comparison of Intravitreal Bevacizumab and Ranibizumab Injections in Aggressive and Type 1 Retinopathy of Prematurity2023 September;64(9)

Effects of Subconjunctival Bevacizumab Injection after Primary Pterygium Surgery2023 August;64(8)

Comparison of Intravitreal Bevacizumab and Aflibercept Injections for Central Serous Chorioretinopathy2021 July;62(7)

The Effect of an Intravitreal Dexamethasone Implant for Refractory Posterior Scleritis2021 March;62(3)

Editorial Office: SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520 Fax: +82-2-583-6521 E-mail: kos08@ophthalmology.org